Obesity has been increasing significantly in Brazil and worldwide, becoming a major public health issue. Traditional prevention and treatment strategies, including behavioral interventions, nutritional modifications, physical activity, pharmacotherapy, and metabolic/bariatric procedures, have proven insufficient to reverse this trend. Bariatric surgery is recognized as the most effective treatment for obesity and its comorbidities, but it carries potential long-term risks. Hybrid Duodenal Transit Bipartition is proposed as a minimally invasive “endobariatric” procedure combining endoscopic sleeve gastroplasty (ESG) with laparoscopic duodenoileal or distal duodenojejunal anastomosis. The main objective of this study is to demonstrate the importance of the intestinal metabolic component of hybrid duodenal transit bipartition. This intestinal component is responsible for optimizing and attempting to maintain weight loss and control comorbidities from an ESG through the incretin stimulus generated by the early arrival of food in the ileum or distal jejunum (duodenoileal or distal duodenojejunal anastomosis). Additionally, it is a minimally invasive procedure that preserves the entire digestive system and does not involve gastrointestinal exclusion, allowing for endoscopic and nutritional access. To date, only one patient has undergone the hybrid duodenal bipartition procedure, with satisfactory early postoperative results at 60 days and weight loss exceeding the scientific literature on patients who underwent isolated endoscopic sleeve gastroplasty. Further studies are needed to validate these results and assess the long-term metabolic benefits of this new approach.
Conde, W.L., Silva, I.V.D. and Ferraz, F.R. (2022) Undernutrition and Obesity Trends in Brazilian Adults from 1975 to 2019 and Its Associated Factors. Cadernos de Saúde Pública , 38, e00149721. https://doi.org/10.1590/0102-311xe00149721
Flores-Ortiz, R., Malta, D.C. and Velasquez-Melendez, G. (2019) Adult Body Weight Trends in 27 Urban Populations of Brazil from 2006 to 2016: A Population-Based Study. PLOS ONE , 14, e0213254. https://doi.org/10.1371/journal.pone.0213254
Kodaira, K., Abe, F.C., Galvão, T.F. and Silva, M.T. (2021) Time-trend in Excess Weight in Brazilian Adults: A Systematic Review and Meta-Analysis. PLOS ONE , 16, e0257755. https://doi.org/10.1371/journal.pone.0257755
Rtveladze, K., Marsh, T., Webber, L., Kilpi, F., Levy, D., Conde, W., et al . (2013) Health and Economic Burden of Obesity in Brazil. PLOS ONE , 8, e68785. https://doi.org/10.1371/journal.pone.0068785
Barboza, L.L.S., Pierangeli Costa, A., de Oliveira Araujo, R.H., Barbosa, O.G.S., Leitão, J.L.A.E.S.P., de Castro Silva, M., et al . (2023) Comparative Analysis of Temporal Trends of Obesity and Physical Inactivity in Brazil and the USA (2011-2021). BMC Public Health , 23, Article No. 2505. https://doi.org/10.1186/s12889-023-17257-4
Elmaleh-Sachs, A., Schwartz, J.L., Bramante, C.T., Nicklas, J.M., Gudzune, K.A. and Jay, M. (2023) Obesity Management in Adults. JAMA , 330, 2000-2015. https://doi.org/10.1001/jama.2023.19897
Alamuddin, N., Bakizada, Z. and Wadden, T.A. (2016) Management of Obesity. Journal of Clinical Oncology , 34, 4295-4305. https://doi.org/10.1200/jco.2016.66.8806
Jirapinyo, P., Hadefi, A., Thompson, C.C., Patai, Á.V., Pannala, R., Goelder, S.K., et al . (2024) American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy Guideline on Primary Endoscopic Bariatric and Metabolic Therapies for Adults with Obesity. Gastrointestinal Endoscopy , 99, 867-885.E64. https://doi.org/10.1016/j.gie.2023.12.004
Arterburn, D.E., Telem, D.A., Kushner, R.F. and Courcoulas, A.P. (2020) Benefits and Risks of Bariatric Surgery in Adults. JAMA , 324, 879-887. https://doi.org/10.1001/jama.2020.12567
Courcoulas, A.P., Daigle, C.R. and Arterburn, D.E. (2023) Long Term Outcomes of Metabolic/Bariatric Surgery in Adults. BMJ , 383, e071027. https://doi.org/10.1136/bmj-2022-071027
ElSayed, N.A., Aleppo, G., Bannuru, R.R., Bruemmer, D., Collins, B.S., Ekhlaspour, L., et al . (2023) 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. Diabetes Care , 47, S145-S157. https://doi.org/10.2337/dc24-s008
Clapp, B., Abi Mosleh, K., Glasgow, A.E., Habermann, E.B., Abu Dayyeh, B.K., Spaniolas, K., et al . (2024) Bariatric Surgery Is as Safe as Other Common Operations: An Analysis of the ACS-NSQIP. Surgery for Obesity and Related Diseases , 20, 515-525. https://doi.org/10.1016/j.soard.2023.11.017
Acosta, A., Streett, S., Kroh, M.D., Cheskin, L.J., Saunders, K.H., Kurian, M., et al . (2017) White Paper AGA: POWER—Practice Guide on Obesity and Weight Management, Education, and Resources. Clinical Gastroenterology and Hepatology , 15, 631-649.E10. https://doi.org/10.1016/j.cgh.2016.10.023
Abu Dayyeh, B.K., Edmundowicz, S. and Thompson, C.C. (2017) Clinical Practice Update: Expert Review on Endoscopic Bariatric Therapies. Gastroenterology , 152, 716-729. https://doi.org/10.1053/j.gastro.2017.01.035
Fayad, L., Adam, A., Schweitzer, M., Cheskin, L.J., Ajayi, T., Dunlap, M., et al . (2019) Endoscopic Sleeve Gastroplasty versus Laparoscopic Sleeve Gastrectomy: A Case-Matched Study. Gastrointestinal Endoscopy , 89, 782-788. https://doi.org/10.1016/j.gie.2018.08.030
Hindsø, M., Svane, M.S., Hedbäck, N., Holst, J.J., Madsbad, S. and Bojsen-Møller, K.N. (2021) The Role of GLP-1 in Postprandial Glucose Metabolism after Bariatric Surgery: A Narrative Review of Human GLP-1 Receptor Antagonist Studies. Surgery for Obesity and Related Diseases , 17, 1383-1391. https://doi.org/10.1016/j.soard.2021.01.041
Hindsø, M., Hedbäck, N., Svane, M.S., Møller, A., Martinussen, C., Jørgensen, N.B., et al . (2022) The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and Β-Cell Function after Roux-En-Y Gastric Bypass and Sleeve Gastrectomy Surgery. Diabetes , 72, 336-347. https://doi.org/10.2337/db22-0568
Hutch, C.R. and Sandoval, D. (2017) The Role of GLP-1 in the Metabolic Success of Bariatric Surgery. Endocrinology , 158, 4139-4151. https://doi.org/10.1210/en.2017-00564
Smith, E.P., Polanco, G., Yaqub, A. and Salehi, M. (2018) Altered Glucose Metabolism after Bariatric Surgery: What’s GLP-1 Got to Do with It? Metabolism , 83, 159-166. https://doi.org/10.1016/j.metabol.2017.10.014
Larraufie, P., Roberts, G.P., McGavigan, A.K., Kay, R.G., Li, J., Leiter, A., et al . (2019) Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery. Cell Reports , 26, 1399-1408.E6. https://doi.org/10.1016/j.celrep.2019.01.047
Novaes, F.S., Vasques, A.C.J., Pareja, J.C., Knop, F.K., Tura, A., Chaim, É.A., et al . (2015) Recovery of the Incretin Effect in Type 2 Diabetic Patients after Biliopancreatic Diversion. The Journal of Clinical Endocrinology & Metabolism , 100, 1984-1988. https://doi.org/10.1210/jc.2014-4042
de Melo, P.R.E., Zorron, R., Dib, V.R.M., Madalosso, C.A.S., Ribeiro, R., Braga, T.C., et al . (2024) Sleeve Gastrectomy with Duodenal Transit Bipartition (S-DTB): Preliminary Results and Technical Aspects of Its Metabolic Structure. Surgical Science , 15, 244-264. https://doi.org/10.4236/ss.2024.154024
de Melo, P.R.E., Braga, T.C., Minari, D.F. and Cardoso Resende, J.H. (2022) Transit Bipartition with Duodeno-Ileal Anastomosis, without Duodenal Exclusion, as a First Stage of Bariatric Surgery in Severely Obese Patients: Case Report. Surgical Science , 13, 497-505. https://doi.org/10.4236/ss.2022.131158
Li, Y., Fang, D. and Liu, T. (2018) Laparoscopic Sleeve Gastrectomy Combined with Single-Anastomosis Duodenal-Jejunal Bypass in the Treatment of Type 2 Diabetes Mellitus of Patients with Body Mass Index Higher than 27.5 kg/m 2 but Lower than 32.5 kg/m 2 . Medicine , 97, e11537. https://doi.org/10.1097/md.0000000000011537
Santoro, S., Milleo, F.Q., Malzoni, C.E., Klajner, S., Borges, P.C.M., Santo, M.A., et al . (2007) Enterohormonal Changes after Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat Obesity and Associated Diseases. Obesity Surgery , 18, 17-26. https://doi.org/10.1007/s11695-007-9371-0
Dziakova, J., Torres, A., Odovic, M., Esteban, J.M., Vázquez-Romero, M., Castillo, A., et al . (2024) Spanish Experience with Latero-Lateral Duodeno-Ileostomy + Sleeve Gastrectomy with Magnet Anastomosis System. Obesity Surgery , 34, 3569-3575. https://doi.org/10.1007/s11695-024-07432-w
Gagner, M., Cadiere, G., Sanchez-Pernaute, A., Abuladze, D., Krinke, T., Buchwald, J.N., et al . (2023) Side-to-Side Magnet Anastomosis System Duodeno-Ileostomy with Sleeve Gastrectomy: Early Multi-Center Results. Surgical Endoscopy , 37, 6452-6463. https://doi.org/10.1007/s00464-023-10134-6
Gagner, M. (2015) Safety and Efficacy of a Side-To-Side Duodeno-Ileal Anastomosis for Weight Loss and Type-2 Diabetes: Duodenal Bipartition, a Novel Metabolic Surgery Procedure. Annals of Surgical Innovation and Research , 9, Article No. 6. https://doi.org/10.1186/s13022-015-0015-0
Schlottmann, F., Ryou, M., Lautz, D., Thompson, C.C. and Buxhoeveden, R. (2021) Sutureless Duodeno-Ileal Anastomosis with Self-Assembling Magnets: Safety and Feasibility of a Novel Metabolic Procedure. Obesity Surgery , 31, 4195-4202. https://doi.org/10.1007/s11695-021-05554-z
Guedes, T.P., Martins, S., Costa, M., Pereira, S.S., Morais, T., Santos, A., et al . (2015) Detailed Characterization of Incretin Cell Distribution along the Human Small Intestine. Surgery for Obesity and Related Diseases , 11, 1323-1331. https://doi.org/10.1016/j.soard.2015.02.011
Holst, J.J., Madsbad, S., Bojsen-Møller, K.N., Svane, M.S., Jørgensen, N.B., Dirksen, C., et al . (2018) Mechanisms in Bariatric Surgery: Gut Hormones, Diabetes Resolution, and Weight Loss. Surgery for Obesity and Related Diseases , 14, 708-714. https://doi.org/10.1016/j.soard.2018.03.003
Valentí, V., Cienfuegos, J.A., Becerril Mañas, S. and Frühbeck, G. (2020) Mechanism of Bariatric and Metabolic Surgery: Beyond Surgeons, Gastroenterologists and Endocrinologists. Revista Española de Enfermedades Digestivas , 112, 229-233. https://doi.org/10.17235/reed.2020.6925/2020
Papamargaritis, D. and le Roux, C.W. (2021) Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery? Nutrients , 13, Article 762. https://doi.org/10.3390/nu13030762
Thaler, J.P. and Cummings, D.E. (2009) Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery. Endocrinology , 150, 2518-2525. https://doi.org/10.1210/en.2009-0367
Lampropoulos, C., Alexandrides, T., Tsochatzis, S., Kehagias, D. and Kehagias, I. (2021) Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature. Obesity Surgery , 31, 4575-4584. https://doi.org/10.1007/s11695-021-05568-7
Tu, J., Wang, Y., Jin, L. and Huang, W. (2022) Bile Acids, Gut Microbiota and Metabolic Surgery. Frontiers in Endocrinology , 13, Article 929530. https://doi.org/10.3389/fendo.2022.929530
Davis, E.M. and Sandoval, D.A. (2020) Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function. In: Comprehensive Physiology , Wiley, 577-595.
Drucker, D.J. (2018) Mechanisms of Action and Therapeutic Application of Glucagon-Like Peptide-1. Cell Metabolism , 27, 740-756. https://doi.org/10.1016/j.cmet.2018.03.001
Andersen, A., Lund, A., Knop, F.K. and Vilsbøll, T. (2018) Glucagon-Like Peptide 1 in Health and Disease. Nature Reviews Endocrinology , 14, 390-403. https://doi.org/10.1038/s41574-018-0016-2
Zheng, W., Li, L. and Li, H. (2022) Phytochemicals Modulate Pancreatic Islet Β Cell Function through Glucagon-Like Peptide-1-Related Mechanisms. Biochemical Pharmacology , 197, Article ID: 114817. https://doi.org/10.1016/j.bcp.2021.114817
Holt, M.K., Richards, J.E., Cook, D.R., Brierley, D.I., Williams, D.L., Reimann, F., et al . (2018) Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food. Diabetes , 68, 21-33. https://doi.org/10.2337/db18-0729
Richard, J.E., Anderberg, R.H., Göteson, A., Gribble, F.M., Reimann, F. and Skibicka, K.P. (2015) Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System. PLOS ONE , 10, e0119034. https://doi.org/10.1371/journal.pone.0119034
Liu, J., Conde, K., Zhang, P., Lilascharoen, V., Xu, Z., Lim, B.K., et al . (2017) Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-Like Peptide-1 in the Paraventricular Hypothalamus. Neuron , 96, 897-909.E5. https://doi.org/10.1016/j.neuron.2017.09.042
Kim, K.S., Park, J.S., Hwang, E., Park, M.J., Shin, H.Y., Lee, Y.H., et al . (2024) GLP-1 Increases Preingestive Satiation via Hypothalamic Circuits in Mice and Humans. Science , 385, 438-446. https://doi.org/10.1126/science.adj2537
Anderberg, R.H., Richard, J.E., Eerola, K., López-Ferreras, L., Banke, E., Hansson, C., et al . (2017) Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight. Diabetes , 66, 1062-1073. https://doi.org/10.2337/db16-0755
Khan, R., Tomas, A. and Rutter, G.A. (2020) Effects on Pancreatic Beta and Other Islet Cells of the Glucose-Dependent Insulinotropic Polypeptide. Peptides , 125, Article ID: 170201. https://doi.org/10.1016/j.peptides.2019.170201
Christensen, M., Vedtofte, L., Holst, J.J., Vilsbøll, T. and Knop, F.K. (2011) Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans. Diabetes , 60, 3103-3109. https://doi.org/10.2337/db11-0979
Nauck, M.A., Quast, D.R., Wefers, J. and Pfeiffer, A.F.H. (2021) The Evolving Story of Incretins (GIP and GLP-1) in Metabolic and Cardiovascular Disease: A Pathophysiological Update. Diabetes , Obesity and Metabolism , 23, 5-29. https://doi.org/10.1111/dom.14496
El, K., Gray, S.M., Capozzi, M.E., Knuth, E.R., Jin, E., Svendsen, B., et al . (2021) GIP Mediates the Incretin Effect and Glucose Tolerance by Dual Actions on Α Cells and Β Cells. Science Advances , 7, eabf1948. https://doi.org/10.1126/sciadv.abf1948
Kagdi, S., Lyons, S.A. and Beaudry, J.L. (2024) The Interplay of Glucose-Dependent Insulinotropic Polypeptide in Adipose Tissue. Journal of Endocrinology , 261, e230361. https://doi.org/10.1530/joe-23-0361
Christensen, M.B., Calanna, S., Holst, J.J., Vilsbøll, T. and Knop, F.K. (2014) Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism , 99, E418-E426. https://doi.org/10.1210/jc.2013-3644
Mathiesen, D.S., Bagger, J.I., Bergmann, N.C., Lund, A., Christensen, M.B., Vilsbøll, T., et al . (2019) The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review. International Journal of Molecular Sciences , 20, Article 4092. https://doi.org/10.3390/ijms20174092
Mayendraraj, A., Rosenkilde, M.M. and Gasbjerg, L.S. (2022) GLP-1 and GIP Receptor Signaling in Beta Cells—A Review of Receptor Interactions and Co-Stimulation. Peptides , 151, Article ID: 170749. https://doi.org/10.1016/j.peptides.2022.170749
NamKoong, C., Kim, M.S., Jang, B., Lee, Y.H., Cho, Y. and Choi, H.J. (2017) Central Administration of GLP-1 and GIP Decreases Feeding in Mice. Biochemical and Biophysical Research Communications , 490, 247-252. https://doi.org/10.1016/j.bbrc.2017.06.031
Gasbjerg, L.S., Helsted, M.M., Hartmann, B., Jensen, M.H., Gabe, M.B.N., Sparre-Ulrich, A.H., et al . (2019) Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide 1 in Healthy Individuals. Diabetes , 68, 906-917. https://doi.org/10.2337/db18-1123
Acuna-Goycolea, C. and van den Pol, A.N. (2005) Peptide YY 3-36 inhibits Both Anorexigenic Proopiomelanocortin and Orexigenic Neuropeptide Y Neurons: Implications for Hypothalamic Regulation of Energy Homeostasis. The Journal of Neuroscience , 25, 10510-10519. https://doi.org/10.1523/jneurosci.2552-05.2005
Alonso, A.M., Cork, S.C., Phuah, P., Hansen, B., Norton, M., Cheng, S., et al . (2024) The Vagus Nerve Mediates the Physiological but Not Pharmacological Effects of PYY 3-36 on Food Intake. Molecular Metabolism , 81, Article ID: 101895. https://doi.org/10.1016/j.molmet.2024.101895
Reidelberger, R., Haver, A. and Chelikani, P.K. (2013) Role of Peptide YY(3–36) in the Satiety Produced by Gastric Delivery of Macronutrients in Rats. American Journal of Physiology-Endocrinology and Metabolism , 304, E944-E950. https://doi.org/10.1152/ajpendo.00075.2013
Düfer, M., Hörth, K., Wagner, R., Schittenhelm, B., Prowald, S., Wagner, T.F.J., et al . (2012) Bile Acids Acutely Stimulate Insulin Secretion of Mouse Β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition. Diabetes , 61, 1479-1489. https://doi.org/10.2337/db11-0815
Brighton, C.A., Rievaj, J., Kuhre, R.E., Glass, L.L., Schoonjans, K., Holst, J.J., et al . (2015) Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors. Endocrinology , 156, 3961-3970. https://doi.org/10.1210/en.2015-1321
Zhu, X., Chen, Z., Zhang, B., Xie, S. and Wang, M. (2024) Bile Acid Injection Regulated Blood Glucose in T2DM Rats via the TGR5/GLP-1 Rather than FXR/FGF15 Pathway. Alternative Therapies in Health and Medicine .
Zheng, X., Chen, T., Jiang, R., Zhao, A., Wu, Q., Kuang, J., et al . (2021) Hyocholic Acid Species Improve Glucose Homeostasis through a Distinct TGR5 and FXR Signaling Mechanism. Cell Metabolism , 33, 791-803.e7. https://doi.org/10.1016/j.cmet.2020.11.017
Bohórquez, D.V., Shahid, R.A., Erdmann, A., Kreger, A.M., Wang, Y., Calakos, N., et al . (2015) Neuroepithelial Circuit Formed by Innervation of Sensory Enteroendocrine Cells. Journal of Clinical Investigation , 125, 782-786. https://doi.org/10.1172/jci78361
Liu, W.W. and Bohórquez, D.V. (2022) The Neural Basis of Sugar Preference. Nature Reviews Neuroscience , 23, 584-595. https://doi.org/10.1038/s41583-022-00613-5
Kaelberer, M.M., Rupprecht, L.E., Liu, W.W., Weng, P. and Bohórquez, D.V. (2020) Neuropod Cells: The Emerging Biology of Gut-Brain Sensory Transduction. Annual Review of Neuroscience , 43, 337-353. https://doi.org/10.1146/annurev-neuro-091619-022657
Drucker, D.J. and Yusta, B. (2014) Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2. Annual Review of Physiology , 76, 561-583. https://doi.org/10.1146/annurev-physiol-021113-170317
Cazzo, E., Gestic, M.A., Utrini, M.P., Chaim, F.D.M., Geloneze, B., Pareja, J.C., et al . (2016) GLP-2: A Poorly Understood Mediator Enrolled in Various Bariatric/Metabolic Surgery-Related Pathophysiologic Mechanisms. ABCD . Arquivos Brasileiros de Cirurgia Digestiva ( São Paulo ), 29, 272-275. https://doi.org/10.1590/0102-6720201600040014
Drucker, D.J. (2001) Glucagon-Like Peptide 2. The Journal of Clinical Endocrinology & Metabolism , 86, 1759-1764. https://doi.org/10.1210/jcem.86.4.7386
Cazzo, E., Pareja, J.C., Chaim, E.A., Coy, C.S.R. and Magro, D.O. (2017) Glucagon-like Peptides 1 and 2 Are Involved in Satiety Modulation after Modified Biliopancreatic Diversion: Results of a Pilot Study. Obesity Surgery , 28, 506-512. https://doi.org/10.1007/s11695-017-2875-3